Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-EP-05
Country
EP
Application Type
National Stage
Patent Status
Abandoned
Patent Number
Publication Number
3082851
Application Number
14824680.4
IC
NCI
Date Filed
Date Issued
Patent PDF